Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA flags heart inflammation risk after taking Novavax COVID vaccine

Ruchika Sharma4 Jun 2022 3:09 PM IST

The FDA said it had requested Novavax to flag myocarditis and another kind of heart inflammation as an "important identified risk" in its materials.

Boehringer Ingelheim, A*STAR ink pact for targeted cancer therapies

Ruchika Sharma4 Jun 2022 10:00 AM IST

A*STAR may receive payments totalling 100 million EUR in upfront and success-based development and commercialization milestones.

Walvax Biotechnology COVID booster stronger against Omicron than Sinovac shot, shows trial data

Ruchika Sharma4 Jun 2022 10:00 AM IST

Beijing: A COVID-19 vaccine candidate from China's Walvax Biotechnology using mRNA technology triggered a stronger antibody response against the...

AstraZeneca discontinues Phase 3 trial of prostate cancer drug Truqap

Researchers identify increase in serious neurological disorder cases following AstraZeneca vaccine

Ruchika Sharma3 Jun 2022 3:23 PM IST

Guillain-Barre syndrome (GBS) is a rare but serious autoimmune condition that attacks the peripheral nervous system, typically resulting in numbness,...

Study says Pfizer COVID drug Paxlovid reduces COVID risk in seniors regardless of vaccine status

Ruchika Sharma3 Jun 2022 1:17 PM IST

Pfizer's clinical trial tested Paxlovid in unvaccinated people who had risk factors for serious disease and found that the two-drug treatment cut the...

Sanofi to transfer 100 percent rights of Libtayo to Regeneron

Ruchika Sharma3 Jun 2022 12:34 PM IST

Upon closing of the transaction, Regeneron will make an upfront payment of $900 million to Sanofi, which will be entitled to receive an 11% royalty on...

Pfizer-BioNTech seeks USFDA authorisation for COVID vaccine for kids under 5 years

Ruchika Sharma3 Jun 2022 11:30 AM IST

No COVID-19 shot is yet approved for children in that age group in most parts of the world.

Cipla adds capacity of captive renewable energy power plant in Maharashtra, Karnataka

Ruchika Sharma3 Jun 2022 10:00 AM IST

The project will support the Company's green energy requirements for its manufacturing units at Kurkumbh & Patalganga and R&D centre at Vikhroli in...

Sanofi gets USFDA breakthrough therapy designation for hemophilia A drug Efanesoctocog alfa

Ruchika Sharma2 Jun 2022 5:03 PM IST

Hemophilia A occurs in about one in 5,000 male births annually, and more rarely in females.

Women more likely to develop skin rash from Moderna COVID vaccine: Japanese study

Ruchika Sharma2 Jun 2022 4:13 PM IST

The symptoms were mild and not considered a contraindication of the mRNA-based vaccine, according to the June 1 report in the Journal of the American...

TG Therapeutics lymphatic cancer treatment Ukoniq no longer authorised by USFDA

Ruchika Sharma2 Jun 2022 3:55 PM IST

The U.S. health regulator said based on updated clinical trial data it has determined that the risks of treatment with Ukoniq outweigh its benefits.

Healthcare recruitment platform Jobizo raises USD 1.4 million in pre-Series A funding

MedTech startup EzeRx raises undisclosed amount as seed funding from Mankind Pharma promoters

Ruchika Sharma2 Jun 2022 3:29 PM IST

The fund raised will be used for scaling up its operations and marketing along with boosting its sales in various markets across India, Africa, and...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok